European Pharmaceutical Review Issue 1 (2026): Environmental Monitoring In-Depth Focus

Environmental monitoring across pharmaceutical manufacturing is coming under increasing pressure to move beyond delayed, culture-based methods towards faster and more actionable insight. This In-Depth Focus examines how rapid microbiological methods, biofluorescent particle counting and AI-enabled analytical technologies are being assessed for use within regulated environments.

Conventional environmental monitoring approaches, built around incubation-based methods, limit how quickly contamination risks can be understood during manufacturing. As attention shifts towards faster alternatives across aseptic production, bioburden testing, raw materials, process water and in-process monitoring, manufacturers are weighing the benefits of improved detection speed against the need to remain aligned with established microbiological and regulatory expectations. At the same time, Annex 1 and Annex 22 are introducing clearer frameworks for how rapid and AI-enabled methods can be validated, controlled and used in GMP settings.

This collection brings together perspectives from Dr Jennifer Isken and Aleš Dimnik (Novartis), alongside Spore.Bio and its scientific team in Paris, outlining how biofluorescent particle counters and rapid microbiological methods are being explored in aseptic manufacturing, and how transformer-based multimodal spectral imaging systems are being developed to enable detection, enumeration and microbial identification without growth enrichment, with outputs aligned to CFU-based reporting and the ability to distinguish viable microorganisms from non-viable particles.

What’s inside this In-Depth Focus

• Moving from delayed microbiology results to near real-time insight in environmental monitoring workflows
• Where biofluorescent particle counters fit into aseptic manufacturing and what is limiting wider adoption
• How Annex 22 is redefining the use of AI and machine learning in GMP-critical microbiological systems
• What AI-driven spectral imaging can deliver beyond traditional rapid methods, including simultaneous detection, count and identification
• How emerging systems align with CFU-based microbiology while defining the boundaries of what they can and cannot detect

Explore how rapid microbiological methods, biofluorescent particle counting and AI-enabled detection technologies are being evaluated in practice to address the real constraints of speed, validation and regulatory compliance in environmental monitoring.